Cite
HARVARD Citation
Odia, Y. et al. (2021). CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA. Neuro-oncology. pp. vi62-vi63. [Online].